The novel approach of tirzepatide peptide represents a exciting advance in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatide-peptide581759.qodsblog.com/42171615/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment